STLN Starling Oncology, Inc.
$6.17▼ -0.48%
Healthcare
Other
After hours
$6.17▲ +0.00%
Sep 11, 7:30 PM ET
Volume 790.9K
Avg Volume (10D) 1.01M
Key Metrics & Fundamentals
Market Cap
$628.82M
P/E Ratio
–
Div Yield
–%
52W Range
2.32 - 7.05
% vs 50 MA
6.91%
% vs 200 MA
49.63%
RSI-14
53.4
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.69
Free Cash Flow
$11.03M
Gross Rev
$161.28M
Gross Profit
$27.17M
EBITDA
-$2.86M
COGS
$134.12M
Operating Exp
$31.78M
Operating Income
-$4.62M
EBIT
-$4.62M
Pretax Income
-$9.79M
Net Income
-$9.79M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Starling Oncology to Participate in Wells Fargo Healthcare Conference
GlobeNewswire · Aug 24, 2026 1:00 PM
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
GlobeNewswire · Aug 17, 2026 12:00 PM
Oncology Institute Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 6:04 PM
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
GlobeNewswire · Aug 6, 2026 8:14 PM
Earnings To Watch: Starling Oncology Inc (STLN) Q2 2026 -- GF Value Sees 44% Downside
GuruFocus.com · Aug 5, 2026 1:37 PM
The Oncology Institute Changes Name to Starling Oncology
MT Newswires · Aug 3, 2026 1:16 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See STLN's money flow as a full page
Social Sentiment
No Reddit posts found for STLN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.